Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS) SHH

Currency In CNY

AD

Valuation

Market Cap25.36B
Enterprise Value25.17B
P/E Ratio8.57
PEG Ratio0.03
Price/Sales Ratio8.56
Price/Book Ratio2.94
Enterprise/Revenue8.49
Enterprise/EBITDA10.59

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.69
Operating Margin0.76
AD

Management Effectiveness

Return On Assets0.33
Return On Equity0.41

Income Statement

Revenue4.2B
Revenue/Share7.03
Gross Profit3.87B
EBITDA3.44B
Net Income2.9B
Diluted EPS4.68

Balance Sheet

Total Cash1.47B
Total Cash/Share2.4
Total Debt0
Total Debt/Equity0
Current Ratio21.99
Book Value Per Share13.97

Price History

52-Week Change8.53
52-Week High66.62
52-Week Low32.26
Moving Average 50 Days47.33
Moving Average 200 Days44.06

Statistics

Average Volume12.03M
Shares Outstanding896.23M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.48
Trailing Annual Dividend Yield1.17
Payout Ratio0.03
Last Split Factor29:20
Last Split DateJune 18, 2026
AD